tiprankstipranks
Trending News
More News >

BrightSpring Health price target raised to $30 from $25 at BTIG

BTIG analyst David Larsen raised the firm’s price target on BrightSpring Health (BTSG) to $30 from $25 and keeps a Buy rating on the shares as part of a broader research note in summary of presentations at the recent Boston Digital Health Summit. The firm is citing the fairly high drug price inflation rates, especially amongst specialty and oncology medications, as well as good volumes, especially in the post-acute environment in boosting its price target on BrightSpring.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1